Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.WuXi PharmaTech has acquired Abgent, a provider of biological research reagent products and services in Suzhou, China, and San Diego, California.
Subscribe to our email newsletter
Following the deal, Abgent would bring new product lines of biological research reagents for drug discovery and basic research to WuXi.
Abgent utilizes production facilities consisting of a 34,000 square-foot laboratory in Suzhou and a 10,000 square-foot laboratory and office in San Diego.
Abgent is known for manufacturing antibody reagents for research use and maintains a catalog of about 20,000 antibody products.
The financial terms of the deal, however, have not been disclosed.